Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (11)
Nature Medicine (2)
Nature Communications (1)
Scientific Reports (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (10)
Correspondence (3)
Amendments and Corrections (2)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cell biology
Diseases
Health care
Immunology
Medical research
Microbiology
Pathogenesis
Risk factors
Signs and symptoms
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–15 of 15 results

Advanced filters: Author: Jörg Halter Clear advanced filters

Chronic gvhd dictionary—eurograft cost action initiative consensus report

Ana Zelić Kerep
Atillio Olivieri
Daniel Wolff
ResearchOpen Access13 Oct 2022
Bone Marrow Transplantation

Volume: 58, P: 68-71
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R Mathew
Francis Baumgartner
Robert Zeiser
Amendments and Corrections01 Apr 2018
Nature Medicine

Volume: 24, P: 526
Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation

Simon Pahnke
Torstein Egeland
Jeff Szer
Research03 Oct 2018
Bone Marrow Transplantation

Volume: 54, P: 858-866
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Combining the kinase inhibitor sorafenib with allogeneic stem cell transplantation boosts immune responses against a subtype of acute myelogenous leukemia, suggesting potential clinical benefit.

Nimitha R Mathew
Francis Baumgartner
Robert Zeiser
Research12 Feb 2018
Nature Medicine

Volume: 24, P: 282-291
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

Aberrant activation of the TGF-β pathway leads to fibrotic disease. Distler and colleagues show that TGF-β-mediated fibrosis requires the decrease of Dickkopf-1, an antagonist of canonical Wnt signalling, suggesting that the two pathways interact for the manifestation of this disease.

Alfiya Akhmetshina
Katrin Palumbo
Jörg H.W. Distler
ResearchOpen Access13 Mar 2012
Nature Communications

Volume: 3, P: 1-12
Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis

Silke Heidenreich
Katharina Egger-Heidrich
Matthias A. Fante
ResearchOpen Access14 Jan 2025
Bone Marrow Transplantation

Volume: 60, P: 439-446
Correction: High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation

Stéphane Buhler
Helen Baldomero
Jean Villard
Amendments and CorrectionsOpen Access04 May 2020
Bone Marrow Transplantation

Volume: 55, P: 1215
BleedHD—a new electronic assessment tool for grading chronic graft-versus-host disease validated in a multicenter and multiprofessional setting

Andrea Warthmann
Andreas Holbro
Jörg Halter
Correspondence01 Mar 2023
Bone Marrow Transplantation

Volume: 58, P: 613-615
Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin

Lina Stutz
Jörg P. Halter
Michael Medinger
ResearchOpen Access04 Jan 2022
Bone Marrow Transplantation

Volume: 57, P: 391-398
Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study

Jérémie Héritier
Michael Medinger
Martina Kleber
ResearchOpen Access08 Feb 2022
Bone Marrow Transplantation

Volume: 57, P: 613-619
Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation

Evgenii Shumilov
Inna Shakhanova
Thomas Pabst
ResearchOpen Access13 Nov 2021
Bone Marrow Transplantation

Volume: 57, P: 224-231
High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation

Stéphane Buhler
Helen Baldomero
Jean Villard
ResearchOpen Access05 Apr 2019
Bone Marrow Transplantation

Volume: 54, P: 1701-1709
Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation

Gioele Capoferri
Carla Simone Walti
Nina Khanna
CorrespondenceOpen Access16 Feb 2023
Bone Marrow Transplantation

Volume: 58, P: 597-599
Baseline calprotectin fails to predict incidence of acute gastrointestinal graft vs. host disease: a prospective study

Nadine Schmidlin
Jakob R. Passweg
Andreas Holbro
Correspondence14 Aug 2018
Bone Marrow Transplantation

Volume: 54, P: 343-347
Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation

M. Beaume
T. Köhler
Patrick Yerly
ResearchOpen Access17 Jan 2017
Scientific Reports

Volume: 7, P: 1-10